Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells
Open Access
- 15 December 2001
- journal article
- Published by American Society of Hematology in Blood
- Vol. 98 (13) , 3784-3792
Abstract
Recent data suggest that mast cells (MCs) in patients with systemic mastocytosis or mast cell leukemia express a CD2-reactive antigen. To explore the biochemical nature and function of this antigen, primary MCs as well as the MC line HMC-1 derived from a patient with mast cell leukemia were examined. Northern blot experiments revealed expression of CD2 messenger RNA in HMC-1, whereas primary nonneoplastic MCs did not express transcripts for CD2. In cell surface staining experiments, bone marrow (BM) MCs in systemic mastocytosis (n = 12) as well as HMC-1 cells (30%-80%) were found to express the T11-1 and T11-2 (but not T11-3) epitopes of CD2. By contrast, BM MCs in myelodysplastic syndromes and nonhematologic disorders (bronchiogenic carcinoma, foreskin phimosis, uterine myeomata ) were consistently CD2−. All MC species analyzed including HMC-1 were found to express LFA-3 (CD58), the natural ligand of CD2. To study the functional role of CD2 on neoplastic MCs, CD2+ and CD2− HMC-1 cells were separated by cell sorting. CD2+ HMC-1 cells were found to form spontaneous aggregates and rosettes with sheep erythrocytes in excess over CD2−cells, and a T11-1 antibody inhibited both the aggregation and rosette formation. Moreover, exposure of CD2+ HMC-1 cells to T11-1 or T11-2 antibody was followed by expression of T11-3. In addition, stimulation of neoplastic MCs through T11-3 and a second CD2 epitope resulted in histamine release. These data show that neoplastic MCs express functionally active CD2. It is hypothesized that expression of CD2 is associated with pathologic accumulation and function of MCs in systemic mastocytosis.Keywords
This publication has 51 references indexed in Scilit:
- Phenotypic Characterization of Human Skin Mast Cells by Combined Staining with Toluidine Blue and CD AntibodiesJournal of Investigative Dermatology, 1998
- The Role of CD2 as a Regulator of Human T‐Cell Cytokine ProductionImmunological Reviews, 1996
- The presence of membrane-bound stem cell factor on highly immature nonmetachromatic mast cells in the peripheral blood of a patient with aggressive systemic mastocytosisJournal of Allergy and Clinical Immunology, 1996
- Expression of lymphoid‐associated antigens in mast cells: report of a case of systemic mast cell diseaseBritish Journal of Haematology, 1995
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.Journal of Clinical Investigation, 1993
- T cell receptor-independent CD2 signal transduction in FcR+ cells.Journal of Experimental Medicine, 1991
- The Biologic Roles of CD2, CD4, and CD8 in T-Cell ActivationAnnual Review of Immunology, 1989
- Systemic Mast Cell DiseaseMedicine, 1988
- Mast Cell Leukemia: Report of a Case and Review of the LiteratureMayo Clinic Proceedings, 1986
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981